Centene
CNC
64.99
+0.38
+0.59%
Centene
US · CNC
#663 by market cap
Listed 1970
64.99
+0.38
+0.59%
Live - 5344 symbols - heartbeat 398s ago
· 2026-10-08 07:32
Pre-market
65.10
+0.17%
After-hours
65.30
+0.48%
Overnight
64.90
-0.14%
- Market cap
- 32.10B
- P/E (TTM)i
- -6.27
- P/Bi
- 1.42
- EPSi
- -13.53
- Div yieldi
- 0.00%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on CNC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Institutional ownership
- Held by institutions
- 100.64% -0.15pp
- Institutions
- 1,210 -5
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund73.56%
Hedge Fund16.08%
Public Company2.96%
Government Pension Fund2.68%
Private Company2.37%
Sovereign Wealth Fund1.82%
Family Office/Trust0.63%
Individual/Insider0.34%
Insurance Company0.26%
Top holders as of 2026-06-30
BlackRock
8.39% · 41.45M sh
Vanguard Capital Management, LLC
6.91% · 34.14M sh
AQR Capital Management
5.70% · 28.15M sh
Vanguard Portfolio Management, LLC
4.52% · 22.35M sh
State Street Global Advisors
4.45% · 21.97M sh
Geode Capital Management, LLC
2.69% · 13.31M sh
Wellington Management Group
2.69% · 13.30M sh
Columbia Management Investment Advisers, LLC
2.51% · 12.42M sh
Harris Associates L.P.
2.25% · 11.12M sh
T. Rowe Price Group, Inc.
1.76% · 8.70M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 29 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| Frederick Eppinger | Independent Chairperson | 0.07% |
| Andrew Asher | Chief Financial Officer | 0.06% |
| Sarah London | Chief Executive Officer | 0.06% |
| Kenneth Burdick | Director | 0.06% |
| Kenneth Fasola | President | 0.02% |
| Theodore Samuels | Independent Director | 0.01% |
| H. Dallas | Lead Independent Director | 0.01% |
| Christopher Coughlin | Independent Director | 0.01% |
| Katie Casso | Senior VP, Chief Accounting Office & Corporate Controller | 0.01% |
| Susan Smith | Chief Operating Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Lauren Tyler | Director | Other Acquisition | +482 | -- |
| 2026-09-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +864 | -- |
| 2026-09-29 | Christopher Coughlin | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Theodore Samuels | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Kenneth Tanji | Director | Other Acquisition | +603 | -- |
| 2026-09-14 | Theodore Pienkos | Corporate Controller & Chief Accounting Officer | Sale to Issuer | -1,092 | $69.41 |
| 2026-08-25 | Kenneth Burdick | Director | Intent to Sell (Form 144) | -43,600 | $65.00 |
| 2026-08-25 | Christopher Koster | General Counsel | Open Market Disposition | -56,500 | $66.90 |
| 2026-08-17 | Christopher Koster | General Counsel | Open Market Disposition | -47,603 | $65.36 |
| 2026-08-04 | Kenneth Burdick | Director | Intent to Sell (Form 144) | -100,000 | $68.15 |
| 2026-07-27 | Paul Diaz | Director | Other Acquisition | +2,771 | -- |
| 2026-07-16 | Lauren Tyler | Director | Other Acquisition | +3,155 | -- |
| 2026-06-29 | Lauren Tyler | Director | Other Acquisition | +61 | -- |
| 2026-06-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +833 | -- |
| 2026-06-29 | Christopher Coughlin | Independent Director | Other Acquisition | +562 | -- |
| 2026-06-29 | Theodore Samuels | Independent Director | Other Acquisition | +465 | -- |
| 2026-06-29 | Kenneth Tanji | Director | Other Acquisition | +581 | -- |
| 2026-06-14 | Susan Smith | Chief Operating Officer | Sale to Issuer | -483 | $65.19 |
| 2026-06-09 | Kenneth Burdick | Director | Open Market Disposition | -80,000 | $64.55 |
| 2026-05-28 | Michael Carson | President & CEO of Medical Business | Derivative Disposition Under Emp | -604 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:32:41 · For reference only, not investment advice and not tailored to your situation.